Mobocertinib

Join the fight against childhood cancer! 🎗️ On International Childhood Cancer Day, we're highlighting the importance of early detection and the role we can all play. Learn more about the WHO's initiative to bridge the survival gap by 2030: #ChildhoodCancer #CancerSurvival #WHOInitiative

NICE guidelines have added the guidance on mobocertinib to the systemic anti-cancer therapy treatment pathways for advanced non-small-cell lung cancer. They would like your feedback on how the treatment pathways present content from different sources (NICE technology appraisal guidance, guideline recommendations, and expert input). To comment, go to the link below on systemic anti-cancer therapy for advanced non-small-cell lung cancer and fill in the pop-up survey.